Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells



The Company
Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company developing novel oncology compounds that target cancer stem cells.
Pipeline
Cancer Stem Cells
Platform
Stemline Therapeutics has developed a Discovery Platform called StemScreen® to identify novel compounds that target and kill CSCs.


News
&
Events
4/18/2012
Stemline Announces Two Clinical Presentations of SL-701 at AACR
4/3/2012
Stemline Files Registration Statement for Proposed Initial Public Offering
3/15/2012
Stemline Appoints Former CEO of Cephalon, Kevin Buchi, to Its Board of Directors
Copyright 2012 - Stemline Therapeutics, Inc. All rights reserved
Stemline